Gainers
- Tenon Medical TNON stock moved upwards by 7.7% to $1.19 during Monday's after-market session. The company's market cap stands at $13.3 million.
- Sorrento Therapeutics SRNE stock moved upwards by 7.15% to $0.28. At the close, Sorrento Therapeutics's trading volume reached 26.7 million shares. This is 234.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $150.9 million.
- T2 Biosystems TTOO shares moved upwards by 7.14% to $1.5. This security traded at a volume of 2.5 million shares come close, making up 1438.1% of its average volume over the last 100 days. The company's market cap stands at $10.9 million.
- Benitec Biopharma BNTC shares rose 6.34% to $0.27. Trading volume for this security closed at 1.2 million, accounting for 310.4% of its average full-day volume over the last 100 days. The company's market cap stands at $7.5 million. The company's, Q2 earnings came out today.
- electroCore ECOR shares moved upwards by 5.89% to $0.37. The market value of their outstanding shares is at $26.3 million.
- OncoSec Medical ONCS stock increased by 5.26% to $1.4. The company's market cap stands at $4.1 million.
Losers
- NeuBase Therapeutics NBSE shares fell 5.1% to $0.37 during Monday's after-market session. NeuBase Therapeutics's trading volume hit 202.2K shares by close, accounting for 66.3% of its average volume over the last 100 days. The company's market cap stands at $12.2 million.
- Rockwell Medical RMTI stock declined by 5.07% to $2.25. The market value of their outstanding shares is at $26.1 million.
- Humacyte HUMA stock declined by 4.99% to $2.86. The company's market cap stands at $294.9 million.
- Adaptive Biotechnologies ADPT shares decreased by 4.9% to $8.26. The company's market cap stands at $1.1 billion.
- Akanda AKAN shares declined by 4.81% to $0.2. Trading volume for this security closed at 564.9K, accounting for 9.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
- Biohaven BHVN stock declined by 4.79% to $16.9. The market value of their outstanding shares is at $1.1 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in